Dr.Reddys Laboratories | DRRD - Operating Expenses

Stock Price
1,317.10
Daily Change
-13.90 -1.04%
Monthly
1.26%
Yearly
12.11%
Q2 Forecast
1,288.12

Dr.Reddys Laboratories reported INR73.6B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Aspen Pharmacare ZAR 13.32B 5.36B Dec/2025
Bharat Petroleum INR 1.09T 121.78B Dec/2025
Cipla INR 60.98B 1.06B Dec/2025
Dr.Reddys Laboratories INR 73.6B 1.79B Dec/2025
Sun Pharmaceuticals INR 111.11B 6.97B Sep/2025
UPL INR 106.63B 780M Dec/2025